Literature DB >> 9842007

Electrical cardioversion of atrial fibrillation or flutter with conscious sedation in the age of cost containment.

B G Goldner1, J Baker, A Accordino, L Sabatino, M DiGiulio, D Kalenderian, D Lin, V Zambrotta, J Stechel, P Maccaro, R Jadonath.   

Abstract

BACKGROUND: The purpose of this study was to compare the safety, efficacy, and cost of conscious sedation administered by electrophysiologists certified in the use of conscious sedation with sedation administered by anesthesiologists during cardioversion of atrial fibrillation or atrial flutter to sinus rhythm. METHODS AND
RESULTS: Patients with hemodynamically stable persistent atrial fibrillation and flutter were included in this study. Group 1 patients (n = 33) were sedated by an anesthesiologist and group 2 patients (n = 26) were sedated by an electrophysiologist. Anesthesiologists used propofol and electrophysiologists used midazolam and morphine for sedation. A cost analysis based on professional charges and cost of medications was performed for both groups and compared. Hospital charges were similar for both groups and were excluded from the cost analysis. Although time to sedation in group 1 was shorter than that in group 2, sedation was adequate in both groups such that no patient in group 1 and only 1 patient in group 2 recalled being shocked. There were no complications in either group. The cost incurred in group 2 was less than that in group 1.
CONCLUSIONS: Sedation administered by electrophysiologists for cardioversion of atrial arrhythmias is safe and cost effective. Midazolam and morphine, the sedative agents administered by electrophysiologists, were effective and well tolerated by patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9842007     DOI: 10.1016/s0002-8703(98)70150-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

1.  Heart transplantation in children with mitochondrial cardiomyopathy.

Authors:  D Bonnet; P Rustin; A Rötig; J Le Bidois; A Munnich; P Vouhé; J Kachaner; D Sidi
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

2.  Sedation by physician with diazepam for DC cardioversion of atrial arrhythmias.

Authors:  P J Pugh; P Spurrell; K Kamalvand; A N Sulke
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

3.  Role of conscious sedation for external cardioversion.

Authors:  R Raipancholia; L Sentinella; M Lynch
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

4.  Effect of circadian rhythm on response to carotid sinus massage.

Authors:  Y Atmaca; A Alpman; M Kilickap; S Murat; D Oral
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

5.  Comparison of electrophysiologic monitors with clinical assessment of level of sedation.

Authors:  Christopher J Chisholm; Joseph Zurica; Dmitry Mironov; Robert R Sciacca; Eugene Ornstein; Eric J Heyer
Journal:  Mayo Clin Proc       Date:  2006-01       Impact factor: 7.616

6.  Synchronised cardioversion for chronic atrail fibrillation.

Authors:  E Aniteye; D Kotei; M Tettey; L Sereboe; F Edwin; A Doku; M Tamatey; K Entsuah-Mensah; S Batista; K Frimpong-Boateng
Journal:  Ghana Med J       Date:  2008-03

7.  Intravenous sedation for cardiac procedures can be administered safely and cost-effectively by non-anesthesia personnel.

Authors:  Anna Kezerashvili; John D Fisher; Jessica DeLaney; Savi Mushiyev; Eileen Monahan; Vanessa Taylor; Soo G Kim; Kevin J Ferrick; Jay N Gross; Eugen C Palma; Andrew K Krumerman
Journal:  J Interv Card Electrophysiol       Date:  2008-02-14       Impact factor: 1.900

8.  Safe and effective use of conscious sedation for defibrillation threshold testing during ICD implantation.

Authors:  Ahmed Al Fagih; Hitham Al Shurafa; Saleh Al Ghamdi; Khaled Dagriri; Ayman Al Khadra
Journal:  J Saudi Heart Assoc       Date:  2010-08-08

9.  The safety and effectiveness of a nurse led cardioversion service under sedation.

Authors:  L Boodhoo; G Bordoli; A R Mitchell; G Lloyd; N Sulke; N Patel
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

10.  Simplified cardioversion service with intravenous midazolam.

Authors:  P J B Hubner; S Gupta; I McClellan
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.